Navigation Links
China Sky One Medical Attended Import and Export Fair to Enhance International Growth Opportunity
Date:5/11/2010

HARBIN, China, May 11 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced the Company attended the 107th China Import and Export Fair (Canton Fair) in Guangzhou from May 1st to 5th, 2010 and generated significant interest from many overseas distributors.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100511/CNTU031 )

At the Canton Fair, over 700 distributors visited China Sky One's booth, drawn to the Company's rich product portfolio, especially its proprietary traditional Chinese medicine (TCM) offerings. China Sky One received strong interest of future cooperation from over 100 distributors, including more than 30 from Thailand, Indonesia, Mexico, Russia, India, the Philippines and other countries, who signed Letters of Intent to advance discussions of possible future international commercial opportunities. Many of these distributors also purchased small quantities of the Company's products for trial distribution in their respective markets.

"We are excited by the interest from so many distributors in China Sky One at the Canton Fair and capitalized on the opportunity to introduce our Company and our diverse product offering to this wide audience of potential future customers," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "We look forward to continuing active dialogues with many of these distributors regarding potential distribution of the Company's pharmaceutical products in new markets to further expand our presence and growth potential in the international arena."

About China Import and Export Fair

China Import and Export Fair, also know as the Canton Fair, is held twice a year in the spring and autumn since it was inaugurated in 1957. It is China's largest trade fair with the most complete variety of goods with the largest attendance and business turnover. It is co-hosted by the Ministry of Commerce of China and the People's Government of Guangdong Province to help foster the development of China's foreign trade and exchange with the rest of the world in terms of politics, economy and culture. Phase three of the Canton Fair, held from May 1st to 5th, included companies from five industries, including medicines, medical devices and health products, textiles and garments, and food and native products. Thousands of exhibitors representing Chinese international trade companies and manufacturers exhibited over 150,000 types of high quality goods at competitive prices, including specialty products from the various regions in China, bringing a new meaning to the phrase "Made in China". To learn more, please visit http://www.cantonfair.org.cn/en/index.asp .

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the ability to expand the Company's customer base, the execution of signed Letters of Intent, and growth and expansion opportunities in international markets, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:

    Company Contact:
     China Sky One Medical, Inc.
     Mr. Stanley Hao, CFO
     Tel:   +86-0451-8703-2617
     Email: stanleyhao@cski.com.cn

     Investor Relations Contact:
     CCG Investor Relations
     Ms. Lei Huang, Account Manager
     Tel:   +1-646-833-3417
     Email: lei.huang@ccgir.com
     Web:   http://www.ccgirasia.com

     Ms. Mabel Zhang, Vice President
     Tel:   +1-310-954-1353
     Email: mabel.zhang@ccgir.com


'/>"/>
SOURCE China Sky One Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Harbinger Research Initiates Coverage on China Baicaotang Medicine, Ltd.
2. China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results
3. China Sky One Medical Announces Preliminary First Quarter 2010 Results; Reschedules Earnings Conference Call
4. China Medicine Announces Conference Call to Discuss First Quarter 2010 Results
5. China Sky One Medical Announces Conference Call to Discuss First Quarter 2010 Results
6. Reportlinker Adds Future of Red Biotechnology in China
7. Chinas first open-access journal Nano Research listed in Science Citation Index
8. Australia Substantially Increases Research Collaboration with China, According to Thomson Reuters Study
9. China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010
10. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
11. China Sky One Medical to Attend Rodman & Renshaw Annual China Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Baltimore, Maryland (PRWEB) , ... ... ... firm, PathSensors, Inc., announced today that in a published evaluation of multiple ... (PNNL), a U.S. Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection ...
(Date:2/23/2017)... ... ... The Greater Gift Initiative, Inc , (GGI) a Winston-Salem, NC 501(c)3 non-profit, ... is to advance global health and highlight the greater good of clinical trial participation ... trial volunteer. The vision of GGI is to serve as a philanthropic connector between ...
(Date:2/23/2017)... and SAN FRANCISCO , ... privately-held regenerative medicine company, and Beyond Type 1, a ... type 1 diabetes, today announced a grant from Beyond ... functional cure for type 1 and other insulin-requiring diabetes.  ... has been developing innovative stem cell-derived cell replacement therapies ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel ... Kendall Research Systems, LLC (KRS) clinical development program. KRS is a neurotechnology ... for research and clinical applications. The terms of the transaction were not disclosed. ...
Breaking Biology Technology:
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... , its innovative, highly flexible and award winning ... customers. iMedNet is a proven Software-as-a-Service ... Electronic Data Capture (EDC), but also delivers an entire ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
Breaking Biology News(10 mins):